Clinical Study

Anemia In End Stage Renal Disease Study Testing And Investigational Drug Daprodustat Anemia Pill Vs. The Standard Of Care (Aranesp) Injections.

Posted Date: Dec 8, 2016

  • Investigator: Shashi Kant
  • Co-Investigator: Shashi Kant
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to test how effective daprodustat (an investigational medicine which has not yet been approved by regulatory agencies such as the United States Food and Drug Administration (FDA)) is compared with epoetin alfa or darbepoetin a

Criteria:

Patients With End Stage Renal Disease Currently On Hemodialysis Or Peritoneal Dialysis For > 90 Days, At Dci Clinics Mcmillan, West Chester Or Western Hills. Currently Receiving Aranesp Injections For Anemia With Stable Hemoglobin Between 8 And 12Mg/Dl At

Keywords:

Erythropoeisis Stimulating Agent, Anemia, Dialysis, Null, Null

For More Information:

Heather J Duncan, Phd
513-559-3362
heather.duncan@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.